Trial Profile
A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2014
Price :
$35
*
At a glance
- Drugs Metformin/nateglinide (Primary) ; Metformin; Nateglinide
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Ildong Pharmaceutical
- 25 Mar 2014 New trial record